Aloe Vesta 2-N-1 Antifungal Topical
Name: Aloe Vesta 2-N-1 Antifungal Topical
- Aloe Vesta 2-N-1 Antifungal Topical brand name
- Aloe Vesta 2-N-1 Antifungal Topical dosage
- Aloe Vesta 2-N-1 Antifungal Topical dosage forms
- Aloe Vesta 2-N-1 Antifungal Topical used to treat
- Aloe Vesta 2-N-1 Antifungal Topical is used to treat
- Aloe Vesta 2-N-1 Antifungal Topical side effects
- Aloe Vesta 2-N-1 Antifungal Topical tablet
- Aloe Vesta 2-N-1 Antifungal Topical adult dose
- Aloe Vesta 2-N-1 Antifungal Topical 1200 mg
Commonly used brand name(s)
In the U.S.
- Aloe Vesta 2-N-1 Antifungal
- Aloe Vesta Antifungal
- Baza Antifungal
- Carrington Antifungal
- Derma Gran AF
- DiabetAid Antifungal Foot Bath
- Fungoid
- Lotrimin AF
- Micatin
- Micro-Guard
- Mitrazol
- Monistat 1
- Monistat Derm
- Neosporin AF
- QC Miconazole Nitrate
- Secura Antifungal
- Soothe & Cool Inzo Antifungal
- Tetterine
- Therasoft Antifungal
- Triple Care Antifungal
- Triple Care EPC
- Zeasorb-AF
Available Dosage Forms:
- Lotion
- Tablet, Effervescent
- Cream
- Ointment
- Powder
- Kit
- Tincture
- Gel/Jelly
- Spray
Therapeutic Class: Antifungal
Chemical Class: Imidazole
Uses For Aloe Vesta 2-N-1 Antifungal
Miconazole belongs to the group of medicines called antifungals. Topical miconazole is used to treat some types of fungus infections.
Some of these preparations may be available without a prescription.
Side Effects
Consult your pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
List Aloe Vesta 2-N-1 Antifungal Ointment side effects by likelihood and severity.Interactions
Consult your pharmacist.
Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
For the Consumer
Applies to miconazole topical: topical cream, topical gel/jelly, topical kit, topical lotion, topical ointment, topical powder, topical spray, topical tablet effervescent, topical tincture
Along with its needed effects, miconazole topical (the active ingredient contained in Aloe Vesta 2 in 1 Antifungal) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking miconazole topical:
- Blistering, burning, redness, skin rash, or other sign of skin irritation not present before use of this medicine
Usual Adult Dose for Vaginal Candidiasis
Vaginal suppository:
1 day therapy: Insert 1200 mg suppository intravaginally at bedtime for 1 day.
3 day therapy: Insert 200 mg suppository intravaginally at bedtime for 3 days.
7 day therapy: Insert 100 mg suppository intravaginally at bedtime for 7 days.
Vaginal cream:
Intravaginally:
2% cream: Insert one applicatorful intravaginally at bedtime for 3 to 7 days.
4% cream: Insert one applicatorful intravaginally at bedtime for 3 days.
Topically: Apply to external vulvar area twice a day for up to 7 days, as needed.
Usual Adult Dose for Tinea Corporis
Topical cream, ointment, powder, spray, or tincture: Apply a thin layer to affected areas twice a day for 4 weeks.
Usual Adult Dose for Tinea Cruris
Topical cream, ointment, powder, or spray: Apply a thin layer to affected areas twice a day for 2 weeks.
Precautions
Patients should be advised to notify their physician if symptoms have not improved after completion of the treatment period and to discontinue use if increased signs of irritation or sensitivity (e.g., redness, itching, burning, blistering, swelling, oozing) develop.
Patients should be reevaluated and the diagnosis reconsidered if no improvement is noted after completion of the treatment period.
Patients should not use miconazole vaginal cream or suppositories if they have abdominal pain, fever, or offensive-smelling vaginal discharge.
Safety and effectiveness of the topical cream, topical ointment, topical powder, topical spray, and topical tincture have not been established in pediatric patients less than 2 years of age. Safety and effectiveness of the vaginal cream and vaginal suppository have not been established in pediatric patients less than 12 years of age.